TY - JOUR
T1 - Rating the preferences for potential harms of treatments for cardiovascular disease
T2 - A survey of community-dwelling adults
AU - Zhang, Guangxiang
AU - Parikh, Puja B.
AU - Zabihi, Soraya
AU - Brown, David L.
N1 - Funding Information:
Dr. Zhang was partially supported by grants from the National Institute on Minority Health and Health Disparities U54MD007584 (formerly U54RR026136) and G12MD007601 (formerly G12RR003061) from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
PY - 2013/5
Y1 - 2013/5
N2 - Background. The Institute of Medicine has called for a new health care paradigm that integrates patient values into discussions of the risks and benefits of treatment. Although cardiovascular disease (CVD) affects one-third of Americans, little is known about how adults regard the potential harms or complications of treatment. Objective. We sought to determine the preferences of community-dwelling adults for 15 potential harms or complications resulting from treatment of CVD. Methods. In a telephone survey, adults older than 18 years residing on Long Island, New York, were asked to score the preferences for 15 potential harms or complications of treatment of CVD on a scale from 0 to 100. All statistical analyses were based on nonparametric methods. Multivariable general linear model analyses were performed to identify demographic factors associated with the score assigned for each adverse outcome. Results. The 807 individuals surveyed generated 723 unique sequences of scores for the 15 outcomes. The ranking of scores from least to most acceptable was stroke, major myocardial infarction (MI), cognitive dysfunction, renal failure, death, prolonged ventilator support, heart failure, angina, sternal wound infection, major bleeding, reoperation, prolonged recovery in a nursing home, cardiac readmission, minor MI, and percutaneous coronary intervention. Demographic factors accounted for less than 7% of the observed variation in the score attributed to each outcome. Conclusions. Individual community-dwelling adults living on Long Island, New York, assign unique values to their preferences for potential harms encountered following treatment of CVD. Thus, risk-benefit discussions and treatment decisions regarding CVD should be harmonized to the value system of each individual.
AB - Background. The Institute of Medicine has called for a new health care paradigm that integrates patient values into discussions of the risks and benefits of treatment. Although cardiovascular disease (CVD) affects one-third of Americans, little is known about how adults regard the potential harms or complications of treatment. Objective. We sought to determine the preferences of community-dwelling adults for 15 potential harms or complications resulting from treatment of CVD. Methods. In a telephone survey, adults older than 18 years residing on Long Island, New York, were asked to score the preferences for 15 potential harms or complications of treatment of CVD on a scale from 0 to 100. All statistical analyses were based on nonparametric methods. Multivariable general linear model analyses were performed to identify demographic factors associated with the score assigned for each adverse outcome. Results. The 807 individuals surveyed generated 723 unique sequences of scores for the 15 outcomes. The ranking of scores from least to most acceptable was stroke, major myocardial infarction (MI), cognitive dysfunction, renal failure, death, prolonged ventilator support, heart failure, angina, sternal wound infection, major bleeding, reoperation, prolonged recovery in a nursing home, cardiac readmission, minor MI, and percutaneous coronary intervention. Demographic factors accounted for less than 7% of the observed variation in the score attributed to each outcome. Conclusions. Individual community-dwelling adults living on Long Island, New York, assign unique values to their preferences for potential harms encountered following treatment of CVD. Thus, risk-benefit discussions and treatment decisions regarding CVD should be harmonized to the value system of each individual.
KW - health state preferences
KW - patient decision making
KW - shared decision making
KW - survey methods
KW - utilities
KW - valuations
UR - http://www.scopus.com/inward/record.url?scp=84877085633&partnerID=8YFLogxK
U2 - 10.1177/0272989X13475717
DO - 10.1177/0272989X13475717
M3 - Article
C2 - 23407665
AN - SCOPUS:84877085633
SN - 0272-989X
VL - 33
SP - 502
EP - 509
JO - Medical Decision Making
JF - Medical Decision Making
IS - 4
ER -